Ionis Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brett Monia, with a market cap of $12.5B.
Based on Q1 2026 filing
Common questions about Ionis Pharmaceuticals
Ionis Pharmaceuticals (IONS) has a market capitalization of $12.5B and trades on NASDAQ.
Ionis Pharmaceuticals has approximately 927 employees.